Could a digital device beat Self-Exercise for sarcopenia?
NCT ID NCT07319377
First seen Jan 06, 2026 · Last updated May 15, 2026 · Updated 19 times
Summary
This study tests a digital therapeutic device (exoDTx) to see if it improves muscle strength more than self-exercise in people with sarcopenia, a condition causing age-related muscle loss. About 130 participants will use the device or exercise on their own for 12 weeks. The main goal is to measure changes in knee strength.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bucheon St. Mary's Hospital
RECRUITINGBucheon-si, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
St.Vincent's hospital
RECRUITINGSuwon, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.